| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/18/2002 | WO2001096299A3 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001094345A3 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 07/18/2002 | WO2001090103A3 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001081377A3 Integrin/adhesion antagonists |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001060370A1 Remedies for endothelin-induced diseases |
| 07/18/2002 | WO2001049295A9 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/18/2002 | WO2001044514A3 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 07/18/2002 | WO2001008682A3 Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | US20020095044 Substituted isoindolinone derivatives |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020094992 Administering growth hormone secretagogue which is 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a, 4,6,7-hexahydro-pyrazolo(4,3-c)pyridin-5-yl)1-(R)-benzyloxymet hyl-2-oxo-ethyl)-isobutyramide, salt or prodrug |
| 07/18/2002 | US20020094987 Amide or thioamide substituted benzimidazole or quinoxaline derivatives; therapeutic utility via inhibition of tumor necrosis factor or phosphodiesterase |
| 07/18/2002 | US20020094970 Compositions and methods for treating an arthritic condition |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094350 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use |
| 07/18/2002 | DE10102048A1 Use of active antithrombin III having endothelial cell proliferation inhibitory activity for combating diseases associated with angiogenesis, e.g. retinopathy, neuropathy, leprosy and cancer |
| 07/18/2002 | CA2776023A1 Fumaric acid amides |
| 07/18/2002 | CA2436876A1 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | CA2434672A1 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | CA2434543A1 Inhibition of pathological angiogenesis in vivo |
| 07/18/2002 | CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | CA2434044A1 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha |
| 07/18/2002 | CA2433960A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors |
| 07/18/2002 | CA2433713A1 Preventives for arthritis |
| 07/18/2002 | CA2433653A1 Regulation of lipids and/or bone density and compositions therefor |
| 07/18/2002 | CA2433623A1 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 07/18/2002 | CA2432114A1 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | CA2430588A1 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/18/2002 | CA2429177A1 Inhibition of nf-.kappa.b by triterpene compositions |
| 07/18/2002 | CA2428075A1 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | CA2395711A1 Pharmaceutical compositions |
| 07/17/2002 | EP1222925A2 Kavalactone as TNF-alpha production inhibitor |
| 07/17/2002 | EP1222683A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 07/17/2002 | EP1222466A2 Method to identify compounds which modulate fra-1 expression fils |
| 07/17/2002 | EP1222459A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 07/17/2002 | EP1222276A2 Polynucleotides and polypeptides encoded thereby |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222251A1 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 07/17/2002 | EP1222208A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 07/17/2002 | EP1222195A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 07/17/2002 | EP1222193A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 07/17/2002 | EP1222191A2 Benzodiazepin derivatives, the production and use thereof |
| 07/17/2002 | EP1222188A1 Novel imidazopyridine carbonitrile compounds |
| 07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP1222170A1 Novel nicotinonitrile compounds |
| 07/17/2002 | EP1222169A1 Novel trisubstituted pyridine compounds |
| 07/17/2002 | EP1222162A1 Novel ltb 4? antagonist, method for the production thereof and its use as a medicament |
| 07/17/2002 | EP1221973A1 CD40 antagonist for treating psoriasis |
| 07/17/2002 | EP1221966A1 Method for reducing the risk of cancer |
| 07/17/2002 | EP1221963A1 Methods of inhibiting osteoclastogenesis |
| 07/17/2002 | EP1221962A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221939A1 Ortho ester lipids |
| 07/17/2002 | EP0977581B1 Histone containing composition to treat rheumatoid arthritis |
| 07/17/2002 | EP0888298B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 07/17/2002 | EP0830374B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/17/2002 | CN1359421A Novel polypeptide and DNA thereof |
| 07/17/2002 | CN1359381A Thiazole-derivaties |
| 07/17/2002 | CN1359302A Remedies for immunoogical diseases |
| 07/17/2002 | CN1359288A Method for improvement of transport across adaptable semi-permeable barriers |
| 07/17/2002 | CN1358542A Jusheng oil and preparation process |
| 07/17/2002 | CN1358532A Traditional Chinese medicine for treating arthralgia-syndrome |
| 07/17/2002 | CN1358526A Traditional Chinese medicine for treaitng osteoporosis |
| 07/17/2002 | CN1358519A External application medicine for treating compression fracture |
| 07/17/2002 | CN1087619C Medicines for treating osteoporosis and their preparing process |
| 07/17/2002 | CA2367825A1 Antithrombin iii for disorders caused by angiogenesis |
| 07/16/2002 | US6420600 Hydroxyalkylphenyldiamides |
| 07/16/2002 | US6420520 Peptides and remedy for bone diseases containing the same as active ingredient |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/16/2002 | US6420415 Thiol compounds, their production and use |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420382 Tyrosine kinase inhibitors |
| 07/16/2002 | US6420376 Amido spiropiperidines promote the release of growth hormone |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420363 Mono- or polyenic carboxylic acid derivatives |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6419955 Process for making bisphosphonate compositions |
| 07/16/2002 | CA2286296C Inhibitors for urokinase receptor |
| 07/11/2002 | WO2002053573A1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053547A1 Alkanoic acid derivatives, process for their production and use thereof |
| 07/11/2002 | WO2002053544A1 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2002053523A1 Tropolone derivative |
| 07/11/2002 | WO2002053522A2 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |